G. CENGİZ SEVAL, "HOW HAVE NOVEL QUADRUPLET AND TRIPLET FRONT-LINE OPTIONS CHANGED THE TREATMENT LANDSCAPE FOR EARLY RELAPSED/REFRACTORY MULTIPLE MYELOMA," Haematology Academy 2024 , 2024
CENGİZ SEVAL, G. 2024. HOW HAVE NOVEL QUADRUPLET AND TRIPLET FRONT-LINE OPTIONS CHANGED THE TREATMENT LANDSCAPE FOR EARLY RELAPSED/REFRACTORY MULTIPLE MYELOMA. Haematology Academy 2024 .
CENGİZ SEVAL, G., (2024). HOW HAVE NOVEL QUADRUPLET AND TRIPLET FRONT-LINE OPTIONS CHANGED THE TREATMENT LANDSCAPE FOR EARLY RELAPSED/REFRACTORY MULTIPLE MYELOMA . Haematology Academy 2024
CENGİZ SEVAL, GÜLDANE. "HOW HAVE NOVEL QUADRUPLET AND TRIPLET FRONT-LINE OPTIONS CHANGED THE TREATMENT LANDSCAPE FOR EARLY RELAPSED/REFRACTORY MULTIPLE MYELOMA," Haematology Academy 2024, 2024
CENGİZ SEVAL, GÜLDANE C. . "HOW HAVE NOVEL QUADRUPLET AND TRIPLET FRONT-LINE OPTIONS CHANGED THE TREATMENT LANDSCAPE FOR EARLY RELAPSED/REFRACTORY MULTIPLE MYELOMA." Haematology Academy 2024 , 2024
CENGİZ SEVAL, G. (2024) . "HOW HAVE NOVEL QUADRUPLET AND TRIPLET FRONT-LINE OPTIONS CHANGED THE TREATMENT LANDSCAPE FOR EARLY RELAPSED/REFRACTORY MULTIPLE MYELOMA." Haematology Academy 2024 .
@conferencepaper{conferencepaper, author={GÜLDANE CENGİZ SEVAL}, title={HOW HAVE NOVEL QUADRUPLET AND TRIPLET FRONT-LINE OPTIONS CHANGED THE TREATMENT LANDSCAPE FOR EARLY RELAPSED/REFRACTORY MULTIPLE MYELOMA}, congress name={Haematology Academy 2024}, city={}, country={}, year={2024}}